drugset / Trial / NCT03579589

The Effect of Sugammadex Versus Neostigmine During Neuromuscular Blockade Reversal

NCT03579589

Phase 1 Completed 40 enrolled Ohio State University
RandomizedParallel-groupOpen-labelTreatment

Summary

Patients who undergo surgery receive drugs called neuromuscular blocking agents (NMBA) that to block the activity of muscles. When the surgery is over, the block needs to be reversed. Suggammadex and neostigmine are examples of drugs that reverse blocks. This study aims to investigate if sugammadex is associated with a significantly reduced time to discharge from the operating room to the postoperative unit when compared to neostigmine.

Timeline

Start
2018-08-15
Primary completion
2019-12-15
Completion
2019-12-15

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Neostigmine Other / unclassified 50 ug/kg
Comparator Sugammadex Other / unclassified 2 mg/kg
Comparator Sugammadex Other / unclassified 4 mg/kg
Comparator Sugammadex Other / unclassified 16 mg/kg

Indications

No indication recorded.